Search Results

Bold Therapeutics has announced that Dr. Do- Youn Oh’s group at Seoul National University College of Medicine, Seoul, South Korea, will be presenting at the AACR Annual Meeting, April 5-10, 2024.

RaySearch Laboratories AB announces that Seoul National University Hospital in South Korea has placed an order for the information oncology system RayCare®*.

Seoul National University Bundang Hospital presented its preliminary study result of seizure monitoring for patients with epilepsy using SK Biopharmaceuticals’ multimodal wearable device at the American Epilepsy Society Annual Meeting 2022 in Nashville, Tennessee, December 2-6.

Genome Insight and Kun-hee Lee Child Cancer & Rare Disease Project Team of SNUH (Seoul National University Hospital), funded by the family of ex-Samsung Group Chairman Kun-hee Lee, announces today a collaborative study for a whole genome sequencing (WGS)-based approach to pediatric solid cancer diagnosis in the clinical setting.

The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

DeepQure, a Seoul based medical device company with a novel, extravascular solution for renal denervation, announced initiation of its Early Feasibility Study for the HyperQure™ system following FDA IDE approval.

SynapCell celebrates today the ten-year anniversary of its partnership with the University of Utah as the prime contract testing site of the National Institute